Denali Therapeutics (DNLI) Non-Current Deffered Revenue (2018 - 2022)
Denali Therapeutics (DNLI) reported Non-Current Deffered Revenue of $479,000 for Q4 2022, down 85.9% from $3.4 million a year earlier.
Powered by 
Analysis
Denali Therapeutics (DNLI) Non-Current Deffered Revenue (2018 - 2022) Analysis & Trends
Dating back to Q1 2018, Denali Therapeutics' Non-Current Deffered Revenue record includes 19 quarters.
- Non-Current Deffered Revenue has declined for four consecutive years, with a four-year compound annual growth rate of -69.8% (FY2018 to FY2022).
- By year, Non-Current Deffered Revenue came in at $3.4 million in FY2021 (-85.4%), $23.33 million in FY2020 (-46.7%), $43.75 million in FY2019 (-23.7%) and $57.35 million in FY2018.
- The Q4 2022 figure ranks as the lowest quarterly Non-Current Deffered Revenue in data going back to Q1 2018.
- Year over year, Non-Current Deffered Revenue gained in two of the last seven quarters, with an average decline of 30.2%.
- The high point for year-over-year Non-Current Deffered Revenue in five years was Q3 2021 (growth of 89.1%); the low point was Q1 2022 (a decline of 89.2%).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Deffered Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | - |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | - |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | - |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | - |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | - |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | - |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | - |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | - |
| 10 | Denali Therapeutics | 3.30 Bn | 3.30 Bn | 3.51 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2022 | 479,000.00 |
| Jun 30, 2022 | 3.40 Mn |
| Mar 31, 2022 | 3.40 Mn |
| Dec 31, 2021 | 3.40 Mn |
| Sep 30, 2021 | 31.31 Mn |
| Jun 30, 2021 | 31.31 Mn |
| Mar 31, 2021 | 31.32 Mn |
| Dec 31, 2020 | 23.33 Mn |
| Sep 30, 2020 | 16.56 Mn |
| Jun 30, 2020 | 19.72 Mn |
| Mar 31, 2020 | 34.75 Mn |
| Dec 31, 2019 | 43.75 Mn |
| Sep 30, 2019 | 47.80 Mn |
| Jun 30, 2019 | 44.56 Mn |
| Mar 31, 2019 | 44.85 Mn |
| Dec 31, 2018 | 57.35 Mn |
| Sep 30, 2018 | 44.45 Mn |
| Jun 30, 2018 | 49.59 Mn |
| Mar 31, 2018 | 51.52 Mn |
API Access
Denali Therapeutics Non-Current Deffered Revenue API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=non-current-deffered-revenue&ticker=DNLI&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "non-current-deffered-revenue", "ticker": "DNLI", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=non-current-deffered-revenue&ticker=DNLI&period=max&api_key=YOUR_API_KEY");
const data = await res.json();